EKF Diagnostics Holdings PLC
LSE:EKF

Watchlist Manager
EKF Diagnostics Holdings PLC Logo
EKF Diagnostics Holdings PLC
LSE:EKF
Watchlist
Price: 27 GBX 0.37% Market Closed
Market Cap: 122.5m GBX
Have any thoughts about
EKF Diagnostics Holdings PLC?
Write Note

EKF Diagnostics Holdings PLC
Investor Relations

EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2002-06-05. The firm's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. Its Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen, Quo-Lab A1c, UltraCrit, DiaSpect, HemataStat II and Creamatocrit Plus. The company operates in Germany, the United States, Russia and the United Kingdom.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Julian Huw Baines M.B.E.
Executive Chairman
No Bio Available
Mr. Stephen Young A.C.M.A.
CFO & Executive Director
No Bio Available

Contacts

Address
SOUTH GLAMORGAN
Penarth
Avon HSE, 19 Stanwell Road
Contacts
+442920710570.0
www.ekfdiagnostics.com